ArticleInternational journal of general medicine2025
Clinicopathological Analysis of 60 Cases of Pulmonary Cryptococcosis.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Transcriptomic and lipidomic analysis of the cryptococcal lung granuloma reveals macrophage boundary programs and sphingolipid remodeling.Nature communications · 2026Article
- Clinical Characteristics and Risk Factors for Cryptococcal Meningitis in Non-Acquired Immunodeficiency Syndrome Patients with Pulmonary Cryptococcosis: A 12-Year Hospital-Based Study.Pathogens (Basel, Switzerland) · 2026Article
- Pulmonary cryptococcosis beyond human immunodeficiency virus: a five-year cohort study of diagnostic challenges, radiologic mimics, and clinical predictors.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pulmonary Cryptococcosis (PC) is an invasive pulmonary fungal disease caused by cryptococcal infection, with diagnosis being challenging and prone to misdiagnosis. This research comprehensively analyzes the clinical, imaging, and pathological characteristics of PC, aiming to enhance diagnostic and therapeutic proficiency for PC. Methods: Clinical data of 60 PC patients diagnosed in our hospital from January 2019 to June 2024 were retrospectively scrutinized. Results: 60 patients were enrolled (40 males, 20 females), with an average age of 49.1±13.3 years. Notably, 47 patients (78.3%) were 40 years old or older. 47 cases had chronic underlying diseases, including 2 AIDS patients. Respiratory symptoms were observed in 33 patients, with cough being the most common. Serum cryptococcal capsular antigen testing was conducted on 52 patients, revealing a diagnostic sensitivity of 44.2% (23/52). Imaging revealed predominant involvement of the right lower lung. A peripheral subpleural distribution pattern was observed in 28 cases (46.7%). Lesions exhibited diverse morphologies: solitary, multiple nodules/masses, patchy/consolidation shadows, and a mixed form of these. The mixed type was most prevalent, with 30 cases. Initially, 56 cases were misdiagnosed as tuberculosis, lung cancer or others prior to pathological confirmation. Histopathology showed granulomas and/or multinucleated giant cells in 57 cases. Cryptococcal yeast cells phagocytosed within these cells appeared as colorless, transparent, round or oval structures (4-15 um in diameter) with a refractile clear halo on HE staining, while methenamine silver and PAS staining highlighted them as black or bright-red, facilitating diagnosis. Eleven patients underwent surgical resection followed by fluconazole therapy, and 45 received fluconazole or itraconazole therapy, with most achieving stable outcomes. Conclusion: PC predominantly impacts men over 40 with chronic comorbidities. Serological tests and imaging may indicate PC, yet a definitive diagnosis necessitates lung biopsy or surgical pathology. Antifungal drugs and/or surgery typically resulted in a favorable prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.